| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |